NCT06270056

Evaluation of Telemedicine Medical Abortion Service in Ecuador

Name: Clinical Trial NCT06270056
Creator: Gynuity Health Projects
Keywords: Pregnancy, Misoprostol, drug, clinical trial, Ecuador

Evaluation of Telemedicine Services to Address Urgent Issues Related to Sexual and Reproductive Rights in Ecuador

Gynuity Health Projects·ClinicalTrials.gov·drugNot yet recruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Pregnancy
Drug/Device/Intervention: Misoprostol
Study type: Observational
Intervention type: drug

Sponsor & location

Primary sponsor: Gynuity Health Projects
Location: Ambato,Quito,Quito, Ecuador

Timeline & enrollment

Phase: N/A
Start date: Feb 01, 2024
End date: Feb 01, 2025
Enrollment: 100 participants

Primary outcome

Adverse events (safety)

Summary

This research seeks to demonstrate that a telemedicine model for the provision of legal abortion services in Ecuador is safe, feasible and acceptable to users requesting a medication abortion and who are less than 12 weeks pregnant.

ICD-10 classifications

Pregnancy confirmedPregnancy-related condition, unspecifiedAbdominal pregnancyPregnancy, not (yet) confirmedOvarian pregnancy

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06270056
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06270056 through Pure Global AI's free database. This phase not specified trial is sponsored by Gynuity Health Projects and is currently Not yet recruiting. The study focuses on Pregnancy. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.